401 related articles for article (PubMed ID: 28719033)
1. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
3. Identification of crucial regulatory relationships between long non-coding RNAs and protein-coding genes in lung squamous cell carcinoma.
Wu X; Ruan L; Yang Y; Mei Q
Mol Cell Probes; 2016 Jun; 30(3):146-52. PubMed ID: 26928440
[TBL] [Abstract][Full Text] [Related]
4. Identifying the driver miRNAs with somatic copy number alterations driving dysregulated ceRNA networks in cancers.
Dou R; Kang S; Yang H; Zhang W; Zhang Y; Liu Y; Ping Y; Pang B
Biol Direct; 2023 Nov; 18(1):79. PubMed ID: 37993951
[TBL] [Abstract][Full Text] [Related]
5. Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.
Roszik J; Wu CJ; Siroy AE; Lazar AJ; Davies MA; Woodman SE; Kwong LN
Sci Rep; 2016 Jan; 6():19649. PubMed ID: 26787600
[TBL] [Abstract][Full Text] [Related]
6. A pan-cancer atlas of cancer hallmark-associated candidate driver lncRNAs.
Deng Y; Luo S; Zhang X; Zou C; Yuan H; Liao G; Xu L; Deng C; Lan Y; Zhao T; Gao X; Xiao Y; Li X
Mol Oncol; 2018 Nov; 12(11):1980-2005. PubMed ID: 30216655
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors.
Ohshima K; Hatakeyama K; Nagashima T; Watanabe Y; Kanto K; Doi Y; Ide T; Shimoda Y; Tanabe T; Ohnami S; Ohnami S; Serizawa M; Maruyama K; Akiyama Y; Urakami K; Kusuhara M; Mochizuki T; Yamaguchi K
Sci Rep; 2017 Apr; 7(1):641. PubMed ID: 28377632
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features.
Lanzós A; Carlevaro-Fita J; Mularoni L; Reverter F; Palumbo E; Guigó R; Johnson R
Sci Rep; 2017 Jan; 7():41544. PubMed ID: 28128360
[TBL] [Abstract][Full Text] [Related]
9. CCG: an integrative resource of cancer protein-coding genes and long noncoding RNAs.
Liu M; Yang YT; Xu G; Tan C; Lu ZJ
Discov Med; 2016 Dec; 22(123):351-359. PubMed ID: 28147217
[TBL] [Abstract][Full Text] [Related]
10. PVT1: a rising star among oncogenic long noncoding RNAs.
Colombo T; Farina L; Macino G; Paci P
Biomed Res Int; 2015; 2015():304208. PubMed ID: 25883951
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.
Yan X; Hu Z; Feng Y; Hu X; Yuan J; Zhao SD; Zhang Y; Yang L; Shan W; He Q; Fan L; Kandalaft LE; Tanyi JL; Li C; Yuan CX; Zhang D; Yuan H; Hua K; Lu Y; Katsaros D; Huang Q; Montone K; Fan Y; Coukos G; Boyd J; Sood AK; Rebbeck T; Mills GB; Dang CV; Zhang L
Cancer Cell; 2015 Oct; 28(4):529-540. PubMed ID: 26461095
[TBL] [Abstract][Full Text] [Related]
12. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
[TBL] [Abstract][Full Text] [Related]
13. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
Zhang W; Wang SL
Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
[TBL] [Abstract][Full Text] [Related]
14. ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer.
Baur B; Bozdag S
Genomics; 2017 Jul; 109(3-4):233-240. PubMed ID: 28438487
[TBL] [Abstract][Full Text] [Related]
15. Identification of druggable cancer driver genes amplified across TCGA datasets.
Chen Y; McGee J; Chen X; Doman TN; Gong X; Zhang Y; Hamm N; Ma X; Higgs RE; Bhagwat SV; Buchanan S; Peng SB; Staschke KA; Yadav V; Yue Y; Kouros-Mehr H
PLoS One; 2014; 9(5):e98293. PubMed ID: 24874471
[TBL] [Abstract][Full Text] [Related]
16. CBNA: A control theory based method for identifying coding and non-coding cancer drivers.
Pham VVH; Liu L; Bracken CP; Goodall GJ; Long Q; Li J; Le TD
PLoS Comput Biol; 2019 Dec; 15(12):e1007538. PubMed ID: 31790386
[TBL] [Abstract][Full Text] [Related]
17. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis reveals clinical phenotypes and oncogenic potentials of long non-coding RNAs across 15 cancer types.
Wang ZL; Li B; Piccolo SR; Zhang XQ; Li JH; Zhou H; Yang JH; Qu LH
Oncotarget; 2016 Jun; 7(23):35044-55. PubMed ID: 27147563
[TBL] [Abstract][Full Text] [Related]
19. Targeted Genomic Screen Reveals Focal Long Non-Coding RNA Copy Number Alterations in Cancer Cell Lines.
Volders PJ; Lefever S; Baute S; Nuytens J; Vanderheyden K; Menten B; Mestdagh P; Vandesompele J
Noncoding RNA; 2018 Sep; 4(3):. PubMed ID: 30217017
[TBL] [Abstract][Full Text] [Related]
20. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
